BioCryst underwriters exercise options; stock offering to top $20M

Home › BioCryst underwriters exercise options; stock offering to top $20M

BioCryst Pharmaceuticals is well on its way to raising more than $20 million to support clinical development of its drug pipeline.

06.10	Atlantic Tropical Weather Outlook
06.10	Tropical Storm Milton Graphics
06.10	Tropical Storm Milton Public Advisory Number 3A
06.10	Summary for Tropical Storm Milton (AT4/AL142024)
06.10	Eastern North Pacific Tropical Weather Outlook
06.10	Hurricane Leslie Graphics
06.10	Hurricane Kirk Graphics
06.10	Hurricane Leslie Forecast Discussion Number 15
More »

je.st